(Q34481214)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

review article

0 references

title

Chronic myeloid leukemia therapy in the era of tyrosine kinase inhibitors--the first molecular targeted treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

main subject

chronic myeloid leukemia

3 references

3 April 2019

28 September 2019

2 October 2019

1 reference

28 September 2019

1 reference

2 October 2019

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Horia Bumbea

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Ana-Maria Vladareanu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Irina Voican

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Diana Cisleanu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Lavinia Barsan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

1 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

Journal of medicine and life

16 February 2020

published in

4 references

3 April 2019

28 September 2019

2 October 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

162-166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

16 February 2020

copyright license

3 references

3 April 2019

28 September 2019

on focus list of Wikimedia project

2 October 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019054

Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019054

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019054

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019054

The biology of chronic myeloid leukemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019054

6 July 2018

Chronic myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019054

6 July 2018

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20968202%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

PubMed publication ID

20968202

1 reference